Cellular and Molecular Mechanisms of Pristimerin in Cancer Therapy: Recent Advances

18Citations
Citations of this article
14Readers
Mendeley users who have this article in their library.

Abstract

Seeking an efficient and safe approach to eliminate tumors is a common goal of medical fields. Over these years, traditional Chinese medicine has attracted growing attention in cancer treatment due to its long history. Pristimerin is a naturally occurring quinone methide triterpenoid used in traditional Chinese medicine to treat various cancers. Recent studies have identified alterations in cellular events and molecular signaling targets of cancer cells under pristimerin treatment. Pristimerin induces cell cycle arrest, apoptosis, and autophagy to exhibit anti-proliferation effects against tumors. Pristimerin also inhibits the invasion, migration, and metastasis of tumor cells via affecting cell adhesion, cytoskeleton, epithelial-mesenchymal transition, cancer stem cells, and angiogenesis. Molecular factors and pathways are associated with the anti-cancer activities of pristimerin. Furthermore, pristimerin reverses multidrug resistance of cancer cells and exerts synergizing effects with other chemotherapeutic drugs. This review aims to discuss the anti-cancer potentials of pristimerin, emphasizing multi-targeted biological and molecular regulations in cancers. Further investigations and clinical trials are warranted to understand the advantages and disadvantages of pristimerin treatment much better.

References Powered by Scopus

Multidrug resistance in cancer: Role of ATP-dependent transporters

4963Citations
N/AReaders
Get full text

Cell Death: Critical Control Points

4263Citations
N/AReaders
Get full text

Matrix Metalloproteinases: Regulators of the Tumor Microenvironment

4193Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Autophagy in cancer resistance to paclitaxel: Development of combination strategies

30Citations
N/AReaders
Get full text

Pristimerin suppresses AIM2 inflammasome by modulating AIM2-PYCARD/ASC stability via selective autophagy to alleviate tendinopathy

16Citations
N/AReaders
Get full text

New advances in the research of clinical treatment and novel anticancer agents in tumor angiogenesis

15Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Chen, R. Z., Yang, F., Zhang, M., Sun, Z. G., & Zhang, N. (2021, May 7). Cellular and Molecular Mechanisms of Pristimerin in Cancer Therapy: Recent Advances. Frontiers in Oncology. Frontiers Media S.A. https://doi.org/10.3389/fonc.2021.671548

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 2

40%

Professor / Associate Prof. 1

20%

Lecturer / Post doc 1

20%

Researcher 1

20%

Readers' Discipline

Tooltip

Design 1

25%

Pharmacology, Toxicology and Pharmaceut... 1

25%

Neuroscience 1

25%

Agricultural and Biological Sciences 1

25%

Save time finding and organizing research with Mendeley

Sign up for free